Social Media Assets
Thank you for supporting the Prostate Cancer Foundation. Take a photo from the event and share it to your favorite social media channel. If you’re looking for copy to include with your photo, simply copy and paste any of the below messages. Step 1: Snap a photo from the event Step. Read More
Challenge Awards-Class of 2017
2017 Movember Foundation - Distinguished Gentleman’s Ride - PCF Challenge Award ($1 Million) Principal Investigators: Douglas McNeel, MD, PhD (University of Wisconsin) Co-Investigators: Glenn Liu, MD (University of Wisconsin), Robert Jeraj, PhD (University of Wisconsin), Christos Kyriakopoulos, MD (University of Wisconsin) Project Title: Broadening T-Cell Activation with PD-1 Blockade to. Read More
Treatment Progress
Thanks in part to research funded by the Prostate Cancer Foundation, standards of care for patients have increased significantly in the last 20 years. With the advent of precision oncology, the hope is that there could be no deaths from prostate cancer in as little as 5 years from now.. Read More
The Tough Guy
This is a love story about a man and his family. Charlie Robison so fiercely loved his wife and daughters that he fought prostate cancer with all his might for 13 years. His family loved him so fiercely in return that they were beside him every step of the way. Read More
Young Investigator Award-Class of 2017
The PCF Young Investigator Award-Class of 2017 recipients are: 2017 Stewart Rahr –PCF Young Investigator Award Sarah Amend, PhD Johns Hopkins University Mentor: Kenneth Pienta, MD Proposal Title: Identification and Characterization of Lethal Disseminated Tumor Cells in Men with High-Risk Prostate Cancer As tumors grow, they leave the environment around them bare. Read More
06/19/2017
Curefunding
Fund Dr. Rettig's research Chip in to help Many vs Cancer raise $300,000 for Dr. Matthew Rettig's groundbreaking research into prostate cancer genes. Read More
06/02/2017
Precision medicine taken to the next level: figuring out why tumors have become drug-resistant
Precision medicine is an emerging strategy for treating cancer, in which the unique mutations that occur in an individual’s tumor are used to select therapies that the tumor will likely be susceptible to. For a new treatment called PARP-inhibitors, this strategy of identifying patients who will benefit has been highly. Read More
“Get checked under the hood. Be a responsible grown-up.”
So, you’re 42. You’re into health and fitness, and fairly attuned to your body: you know something’s not right with your urinary tract, and you go to the doctor to get it checked out. Prostate cancer’s not on your radar. Why should it be? You’re young, you’re healthy, you have. Read More
2017 Prostate Cancer Survey
At PCF, we proudly work every day to advance world-class research in an effort to prevent and, eventually, eradicate prostate cancer. We firmly believe that fostering an open and inclusive community is the fastest way to move our research forward. That is why I am so proud to announce our. Read More
05/11/2017
Will Your Cancer Respond to Hormone Therapy?
Hormone therapy is a standard treatment for metastatic prostate cancer patients but may also benefit a subset of localized prostate cancer patients who underwent surgery but have particularly aggressive disease. However, it is not clear how to identify which localized disease patients should receive hormone therapy, and the historical protocol. Read More